RNTX Rein Therapeutics, Inc. Common Stock

XNAS
Find condors

Stock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership. Iron condor setups Fibonacci levels Insider trading

Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.

RNTX — —
Key stats
About
Industry (SIC)
PHARMACEUTICAL PREPARATIONS (2834) · industry map
Exchange
XNAS
Market Cap
$0.1B
Employees
10
List Date
2017-06-29
CIK
0001420565
Next Earnings
2026-11-13
EPS Forecast
($0.10) (1 est.)
Headquarters
Austin, TX
Homepage
https://www.reintx.com

Rein Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing novel therapies for the treatment of orphan pulmonary and fibrosis indications with no approved or limited effective treatments. Its pipeline includes: LTI-03, a peptide, for placebo-controlled safety, tolerability, and pharmacodynamic biomarker activity trial in development for the treatment of Idiopathic Pulmonary Fibrosis, that has demonstrated the ability to protect healthy lung epithelial cells and reduce pro-fibrotic signaling; LTI-01, a proenzyme that completed a Phase 2a dose-ranging, placebo-cont…

Summary
—
composite
—
No summary data available for this symbol yet.

Each spoke is this symbol's rank within its sector (0–100; the dotted ring marks the sector median at 50). Higher is more constructive for a long. One spoke — News sentiment — is an absolute reading, not a sector rank. Grayed spokes have no data. A fuller shape is a summary, not a recommendation.

Chart
Seasonality
'25'26Avg
Jan2.07%4.00%3.04%
Feb8.85%-11.63%-1.39%
Mar-6.84%9.24%1.20%
Apr-2.29%11.98%4.85%
May18.90%7.77%13.33%
Jun-27.46%-2.80%-15.13%
Jul-19.66%-23.96%-21.81%
Aug25.23%0.59%12.91%
Sep-15.19%6.82%-4.18%
Oct32.63%-31.56%*0.54%
Nov-10.29%---10.29%
Dec-22.67%---22.67%
Total-31.52%-34.15%-32.83%
* Only 2 year(s) of data available.
Technical Indicators

Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.

Trend Indicators
  • SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
  • EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
  • MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
  • ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
  • +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
Momentum Oscillators
  • RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
  • Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
  • Williams %R — inverted scale: <−80 oversold, >−20 overbought.

Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.

Volume & Volatility
  • Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
  • OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
  • Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
  • ATR / True Range — average daily $ move; sizing and stop-loss reference.
  • HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.

Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →

Trend Indicators

SMA 20: $0.71
SMA 50: $0.75
SMA 200: $1.05
Current: $0.58
EMA 12: $0.64
EMA 26: $0.69
MACD: -0.0555 | Signal: -0.0125
BEARISH
ADX (14): 25.76
TREND
+DI: 13.43
−DI: 26.02

Momentum Oscillators

RSI (14): 36.86
NEUTRAL
Stoch %K: 16.25
Stoch %D: 18.61
Williams %R: -84.43

Volume & Volatility

BB Upper: $0.92
BB Lower: $0.50
NEUTRAL
OBV: 35,420,127
Vol SMA 20: 469,334
Vol ROC: 264.49%
ATR: $0.06
True Range: $0.05
HV 20: 119.4%
HV 30: 109.0%
HV 60: 89.6%

Data Summary

Data Points: 449
Last Updated:
Date Range: 2025-01-13T00:00:00 – 2026-10-26T00:00:00
AI Analysis

LLM Stock Analysis Report: RNTX

Executive Summary

Overall Assessment: BEARISH (confidence level 7/10)

Key Drivers:

  • Technical indicators suggest a bearish trend, with the MACD signal line crossing below the zero line
  • Recent news headlines have been primarily positive, but may not be enough to overcome the bearish technical signals

Primary Risks:

  • High volatility, as indicated by the beta value of 1.54
  • Negative earnings surprise could exacerbate the decline

Investment Thesis: RNTX is experiencing a bearish trend due to its high volatility and negative technical indicators. While recent news has been positive, the stock's momentum is likely to continue downwards unless a significant catalyst emerges.

Recent News Sentiment Impact: The positive news headlines may have contributed to some short-term price movements, but they do not appear to be sufficient to overcome the bearish trend.

Technical Analysis

Trend Direction: Short-term (1-4 weeks): BEARISH Medium-term (1-3 months): BEARISH Long-term (3-12 months): NEUTRAL

Support/Resistance Levels:

  • Upper Bollinger Band: $1.30
  • Middle Bollinger Band: $1.10
  • Lower Bollinger Band: $0.91
  • SMA 20: $1.10
  • SMA 50: $1.33

Momentum Signals:

  • RSI interpretation: NEUTRAL (40.97)
  • MACD signal line: BEARISH (-0.10 / Signal: 0.00 / Histogram: -0.10)
  • Bollinger Bands position: NEUTRAL (price touching middle band)

Volume Analysis: Volume trends and institutional interest signals:

  • Volume SMA 20: 1524439.10
  • On-Balance Volume (OBV): 32850987.29
  • Volume Rate of Change: -51.79%

News & Sentiment Analysis

Recent Headlines Summary: The news headlines have been primarily positive, highlighting the company's recent funding and clinical trial developments.

Sentiment Assessment: POSITIVE sentiment dominates, but may not be enough to overcome the bearish technical signals.

Catalyst Identification: No significant catalysts are apparent at this time, but a negative earnings surprise could exacerbate the decline.

Market Narrative: The market is generally positive about RNTX's prospects, but the recent news headlines do not appear to be sufficient to overcome the bearish trend.

Risk & Volatility Assessment

Beta Interpretation: High risk relative to the market (beta >1.5)

Volatility Regime: High volatility - stock moves more than the market

Options Market Signals: No options data available, but implied volatility is likely high given the company's recent funding and clinical trial developments.

Downside Protection: Support levels are present at the lower Bollinger Band ($0.91) and the SMA 20 ($1.10).

Market Context & Positioning

Sector Performance: RNTX's sector performance has been mixed, with some companies performing well while others have struggled.

Institutional Activity: Institutional interest is not apparent from the volume data, but the company's recent funding may attract more attention in the future.

Correlation Analysis: The stock moves independently of the market, suggesting high risk and volatility.

Relative Valuation: RNTX is trading below its historical mean, which could be a buying opportunity for some investors.

Key Levels & Action Items

Critical Price Levels:

  • Lower Bollinger Band: $0.91
  • SMA 20: $1.10
  • Upper Bollinger Band: $1.30

Breakout/Breakdown Levels: None apparent at this time, but a breakout above the upper Bollinger Band could signal a reversal.

Time-Sensitive Catalysts: No significant catalysts are apparent at this time, but a negative earnings surprise could exacerbate the decline.

Risk Management:

  • Stop-loss levels should be set below the lower Bollinger Band ($0.91) to manage risk.
  • Position sizing considerations should take into account the company's high volatility and potential for large price movements.
Generated

RNTX Options Activity & IV Rank

Loading options activity...
Spread Scanner GPU
Full Algorithm Docs ↗

Each spread is ranked by a composite score built in three stages. Full documentation →

Stage 1 — Base Score (GPU scanner)

score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.

Stage 2 — Skew Adjustment (±25% cap)

RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.

Stage 3 — Technical Overlay (±50% cap, 5 groups)
Group 1 · Directional Bias (±0.25)
  • RSI <40 bullish / >60 bearish
  • MACD crossover + histogram trend
  • Price vs SMA 50 & SMA 200
Group 2 · Momentum (±0.10)
  • Stochastic %K <20 / >80
  • Williams %R <−80 / >−20
Group 3 · Volatility (up to −0.25 / +0.15)
  • Blended ATR + straddle expected-move penalty
  • Bollinger Band signal (+ counter-trend penalty)
  • BB width — vol contraction boost for ICs
Group 4 · IV Regime (±0.15)
  • IV rank ≥ 75 → strong boost for credit spreads
  • IV rank < 25 → penalty (selling cheap vol)
Group 5 · Liquidity (penalty up to −0.10)
  • Min open interest across all legs
  • OI < 100 → −0.10 · OI < 500 → −0.05

score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →

Enter a ticker to scan for optimal spread opportunities.

Evaluates all bull put, bear call, iron condor, and calendar spread combinations using GPU-accelerated analysis.

Skew (Wing IV − ATM IV)
DTE:
Wing Δ:
Metric:
Wing vs ATM
IV(put wing) − IV(ATM), in vol points

How much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.

  • Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
  • Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
  • Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
  • Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.
Risk Reversal
IV(call wing) − IV(put wing), equal delta on each side

Which side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.

  • Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
  • Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
  • Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
  • Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.
Reading them together

Wing-vs-ATM tells you how expensive the tails are. Risk Reversal tells you which side is favored. Combined:

  • High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
  • Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
  • Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.
14 DTE / 10d —
— pts EXTREME
ATM — / Wing —
30 DTE / 10d —
— pts EXTREME
ATM — / Wing —

Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.

Volatility Surface

Enter a ticker to render the implied volatility surface.

Volatility Smile

Enter a ticker to render the implied volatility smile.

IV Rank (7 DTE)
IV Rank (30 DTE)
Straddle Price (30 DTE)
Beta Analysis

Risk Metrics

Beta: 2.0254
Alpha: -78.27%
Correlation: 0.2949
R-Squared: 8.7%
Stock Volatility: 87.5%
Market Volatility: 12.7%

Analysis Details

Benchmark: SPY
Data Points: 251
Period: 252 trading days
Interpretation:
High volatility - stock moves more than market
Beta & Alpha Over Time
Notable investors who own RNTX
3 of 37 tracked investors
InvestorValueShare of their portfolioRankQ/Q sharesSource
Citadel Hedge fund
Ken Griffin
$2.5M
0.00%
#2679 of 6285new13F
Renaissance Technologies Hedge fund
Jim Simons
$20K
0.00%
#3095 of 3138-22.4%13F
Rockefeller Capital Management Family office
Rockefeller family
$5K
0.00%
#4225 of 47290.0%13F

Hedge funds, activists, holding companies and family offices we track, from their latest 13F (quarter-end value) and Form 4 filings in the last 3 years. Family offices · all institutions

RNTX Institutional Ownership (13F)

Latest filings — 2026-09-30

Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.

  • Shares — long equity positions in this name, aggregated across share classes.
  • Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
  • % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
  • Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.

Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.

66 filers41,956,333 shares$43.68M value
# Filer Shares Value % of Total % of Float Period
1 Voss Capital, LP 5,261,921 $5.47M 12.53% — 2026-06-30
2 Cable Car Capital, LP 5,195,000 $5.40M 12.37% — 2026-06-30
3 ADAR1 Capital Management, LLC 4,500,000 $4.68M 10.71% — 2026-06-30
4 Vanguard Capital Management LLC 3,377,910 $3.51M 8.04% — 2026-06-30
5 BIOS Capital Management, LP 2,982,375 $3.10M 7.10% — 2026-06-30
6 Ikarian Capital, LLC 2,950,000 $3.07M 7.02% — 2026-06-30
7 GREAT POINT PARTNERS LLC 2,575,000 $2.68M 6.13% — 2026-06-30
8 Citadel Advisors LLC Custodian 2,438,711 $2.54M 5.81% — 2026-06-30
9 Velan Capital Investment Management LP 1,700,000 $1.77M 4.05% — 2026-06-30
10 Vanguard Group Inc Custodian 1,165,807 $1.35M 3.10% — 2025-12-31
11 Senvest Management, LLC 1,230,895 $1.28M 2.93% — 2026-06-30
12 Prosight Management, LP 1,100,000 $1.14M 2.62% — 2026-06-30
13 Bleichroeder LP 1,000,000 $1.04M 2.38% — 2026-06-30
14 BOOTHBAY FUND MANAGEMENT, LLC 889,450 $925.03K 2.12% — 2026-06-30
15 Geode Capital Management, LLC Custodian 733,139 $762.54K 1.75% — 2026-06-30
16 UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO 511,610 $532.07K 1.22% — 2026-06-30
17 Vanguard Fiduciary Trust Co 382,515 $397.82K 0.91% — 2026-06-30
18 State Street Corp 379,604 $394.79K 0.90% — 2026-06-30
19 Empery Asset Management, LP 370,834 $385.67K 0.88% — 2026-06-30
20 BlackRock, Inc. Custodian 326,204 $339.25K 0.78% — 2026-06-30
21 Texas Capital Bank Wealth Management Services Inc 300,758 $312.79K 0.72% — 2026-06-30
22 Sigma Planning Corp 357,477 $287.41K 0.66% — 2026-09-30
23 Sequoia Financial Advisors, LLC 250,000 $260.00K 0.60% — 2026-06-30
24 GAGNON SECURITIES LLC 229,070 $238.23K 0.55% — 2026-06-30
25 Stonepine Capital Management, LLC 218,038 $226.76K 0.52% — 2026-06-30
# Filer Notional Value % of Total Period
# Filer Notional Value % of Total Period

RNTX Insider Trading (Form 4)

Latest: 2026-05-28
Form 4 filings — insider beneficial-ownership changes by officers, directors, and 10%+ holders. Filed within 2 business days of transaction.
Filed Reporter Role Action Shares Avg Price Net $ Link
2026-05-28 Josef H Von Rickenbach Director Buy (P) +47,060 $1.05 $49.6K EDGAR
2026-05-13 James Brian Windsor See Remarks Buy (P) +25,000 $1.00 $25.0K EDGAR
2025-11-18 Travis W. Cocke 10%+ Owner Buy (P) +520,915 $1.22 $638.0K EDGAR
2025-10-28 Voss Value-Oriented Special Situations Fund, LP 10%+ Owner Buy (P) +1,530,250 $1.38 $2.12M EDGAR
2025-07-23 Manuel Aivado Director Grant (A) +17,500 opt — EDGAR
2025-07-23 Reinhard J. Ambros Director Grant (A) +17,500 opt — EDGAR
2025-07-23 Josef H Von Rickenbach Director Grant (A) +17,500 opt — EDGAR
2025-07-23 Alan A Musso Director Grant (A) +17,500 opt — EDGAR
2025-07-23 William Fairey Director Grant (A) +17,500 opt — EDGAR
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (described in filing footnote — typically 401(k), trust, inheritance) · W = will/inheritance. Only P / S codes carry directional signal.

RNTX Insider Holdings

4 insiders · @ $0.58
Officers, directors, and 10%+ owners who have filed a Form 4 in the past two years, ranked by current disclosed exposure (shares × today's price). Shares are direct + indirect (via trusts / LLCs / spouse). Excludes unvested RSU and option grants — those aren't beneficially owned until vest.
# Insider Role Shares Disclosed Exposure Lifetime OM Net Filings Last Filed
1 Voss Value-Oriented Special Situations Fund, LP 10%+ Owner 729,616 $425.5K $2.12M 1 2025-10-28
2 Travis W. Cocke 10%+ Owner 500,000 $291.6K $638.0K 1 2025-11-18
3 Josef H Von Rickenbach Director 58,014 $33.8K $49.6K 2 2026-05-28
4 James Brian Windsor See Remarks 27,046 $15.8K $25.0K 1 2026-05-13
Lifetime OM Net = signed sum of open-market buys (P) and sells (S) over their career; excludes grants, tax withholdings, and dispositions to issuer. A large negative number is normal for long-tenured executives — they've sold compensation grants over many years.

RNTX Board & Officers

As of SEC filings through May 28, 2026

Directors 5

Officers 1

10% owners 5

Changes in the last 10 years (99)
May 13, 2026James Brian Windsor first listed as a director in an SEC filing
Feb 16, 2026The company announced the departure of Manuel Aivado from the board in an SEC filing
Sep 24, 2025Voss Value-Oriented Special Situations Fund, LP became a 10% owner
Sep 24, 2025Voss Value Master Fund, LP became a 10% owner
Sep 24, 2025Voss Capital, LP became a 10% owner
Sep 24, 2025Voss Advisors GP, LLC became a 10% owner
Sep 24, 2025Travis W. Cocke became a 10% owner
Dec 4, 2024James Brian Windsor listed as President and CEO (previously President and COO) in SEC filings
Aug 22, 2024Manuel Aivado no longer listed as President and Chief Executive Officer in SEC filings
Jun 17, 2024University of Texas/texas Am Investment Management Co reported in an SEC filing no longer being a 10% owner
May 16, 2024Timothy M. Cunningham became an officer
May 15, 2024The company announced the departure of Charles Garner as Senior Vice President, Finance in an SEC filing
Mar 25, 2024Charles Garner became Senior Vice President, Finance
Feb 28, 2024University of Texas/texas Am Investment Management Co became a 10% owner
Oct 31, 2023William Fairey became a director
Oct 31, 2023The company announced the departure of William McKee from the board in an SEC filing
Oct 31, 2023The company announced the departure of Jodie Pope Morrison from the board in an SEC filing
Oct 31, 2023The company announced the departure of Jeffrey Allen Bailey from the board in an SEC filing
Oct 31, 2023James Brian Windsor became President and COO
Oct 31, 2023Alan A Musso became a director
Not reported recently (16)
  • Timothy M. Cunningham · Last reported as an officer in an SEC filing dated May 16, 2024
  • Nolan Howard Sigal · Last reported as a director in an SEC filing dated Jun 17, 2022
  • Susan L. Drexler · Last reported as an officer in an SEC filing dated Jun 17, 2022
  • Allen Annis · Last reported as SVP, Research in an SEC filing dated Mar 30, 2022
  • Muneer A Satter · Last reported as a director in an SEC filing dated Jan 8, 2021
  • Kathryn Gregory · Last reported as SVP, Chief Business Officer in an SEC filing dated Feb 4, 2020
  • John H McArthur · Last reported as a director in an SEC filing dated Jun 21, 2019
  • Donald Dougherty · Last reported as SVP & Chief Financial Officer in an SEC filing dated Apr 17, 2019
  • Scott Kapnick · Last reported as a director in an SEC filing dated Aug 14, 2018
  • John P Phd Longenecker · Last reported as President and CEO in an SEC filing dated Aug 14, 2018
  • Armen Shanafelt · Last reported as a director in an SEC filing dated Jun 25, 2018
  • Caleb Maxfield Winder · Last reported as a director in an SEC filing dated Jun 25, 2018
  • III Yanchik Joseph A. · Last reported as a director in an SEC filing dated Jul 27, 2017
  • Kira Nelson · Last reported as Vice President, Finance and Operations in an SEC filing dated Jul 27, 2017
  • Brian M. Gallagher Jr. · Last reported as a director in an SEC filing dated Jul 27, 2017
  • Glaxosmithkline Plc · Last reported as a 10% owner in an SEC filing dated Jun 28, 2017
Compiled from SEC filings by the company and its directors and officers. Dates are as stated in those filings. Where no filing says when someone left, we show the last filing that listed them.

RNTX Proposed Insider Sales (Form 144)

Latest: 2024-04-29
Last 30d: 0 filings  ·  Last 90d: 0 filings

What is Form 144? A notice of intent to sell restricted or control stock under Rule 144. Affiliates (officers, directors, 10%+ owners) and holders of restricted shares must file Form 144 when planning to sell more than 5,000 shares or $50,000 in any 3-month rolling window.

How it relates to Form 4: Form 144 is filed before the trade (up to 90 days in advance); Form 4 is filed within 2 business days after the trade executes. Not every Form 144 results in a sale — the filer may cancel or delay. Look for the corresponding Form 4 on the Insider Activity card to confirm a sale actually happened.

10b5-1 plans: Trades made under a pre-scheduled Rule 10b5-1 plan are not discretionary — they execute automatically on dates set months earlier, regardless of news. High 10b5-1 percentages mean less per-filing signal value, though cumulative selling volume still matters.

"Notice value": Aggregate market value the filer wrote into the Form 144 — i.e. the size of the planned sale, not necessarily the executed dollars. An amended notice (Form 144/A) replaces the original it amends, and cancelled notices are dropped, so neither is double-counted above. A filed value that is clearly inconsistent with the share count at the stock's price (a filer typo) shows as a dash and is left out of the totals.

Source & freshness: Sourced from public Form 144 filings. Refreshed daily; new filings typically appear here the morning after they are filed.

Filed Filer Role Shares Notice Value Planned Sale Broker Plan Link
2024-04-29 UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGMENT CO 10% Stockholder 723,984 $3.62M 2024-04-29 Stifel Nicolaus & Company Inc. — EDGAR
Notice value is the aggregate market value the filer states they intend to sell — not a confirmed transaction. Compare to Insider Activity (Form 4) to see which planned sales actually executed. Market-wide feed: Planned sales (Form 144).
ETF Holders
4 ETFs hold RNTX
4 shown · $2.75M total exposure · 0.00% AUM-weighted avg weight
# ETF Provider Weight $ Exposure ETF AUM As Of
1 VTI Vanguard Morningstar Total Stock Market ETF Vanguard 0.00% $2.0M — 2026-09-30
2 VXF Vanguard Extended Market ETF Vanguard 0.00% $631,577 — 2026-09-30
3 IWC iShares Micro-Cap ETF iShares (BlackRock) 0.00% $46,344 $1.2B 2026-10-23
4 ONEQ Fidelity Nasdaq Composite Index ETF Fidelity 0.00% $44,619 $10.7B 2026-10-23
Fundamentals

Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.

Metrics
  • Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
  • Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
  • Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
  • Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
How to read the bars
  • Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
  • YoY growth — compare to the same quarter a year earlier to remove seasonality.
  • Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
  • Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.

TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.